 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
6-5-2019
Insider Buy |
Laurent Humeau
Chief Scientific Officer |
$2.50
CAGR »
|
$50,000.00
20,000 shares |
1-13-2020
Insider Buy |
Jong Joseph Kim
Chief Executive Officer |
$3.11
CAGR »
|
$69,975.00
22,500 shares |
8-30-2019
Insider Buy |
Laurent Humeau
Chief Scientific Officer |
$2.22
CAGR »
|
$9,990.00
4,500 shares |
3-27-2017
Insider Buy |
Morton Collins
Director |
$6.25
CAGR »
|
$133,188.90
21,300 shares |
6-28-2016
Insider Buy |
Morton Collins
Director |
$9.13
CAGR »
|
$91,309.00
10,000 shares |
4-15-2016
Insider Buy |
Morton Collins
Director |
$9.52
CAGR »
|
$650,924.82
68,400 shares |
9-30-2015
Insider Buy |
Niranjan Sardesai
Chief Operating Officer |
$5.50
CAGR »
|
$22,000.00
4,000 shares |
8-14-2015
Insider Buy |
Simon X. Benito
Director |
$7.21
CAGR »
|
$43,257.60
6,000 shares |
4-13-2015
Insider Buy |
Angel Cabrera
Director |
$9.53
CAGR »
|
$76,240.00
8,000 shares |
10-9-2014
Insider Buy |
Peter Kies
CFO |
$10.10
CAGR »
|
$39,996.00
3,960 shares |
8-21-2014
Insider Buy |
Morton Collins
Director |
$10.01
CAGR »
|
$80,089.60
8,000 shares |
8-20-2014
Insider Buy |
Morton Collins
Director |
$9.74
CAGR »
|
$395,391.32
40,600 shares |
8-12-2014
Insider Buy |
Niranjan Sardesai
Chief Operating Officer |
$8.70
CAGR »
|
$22,185.00
2,550 shares |
11-13-2013
Insider Buy |
Morton Collins
Director |
$1.82
CAGR »
|
$463,317.25
254,500 shares |
4-16-2013
Insider Buy |
Mark Bagarazzi
Chief Medical Officer |
$0.56
CAGR »
|
$33,540.00
60,000 shares |
4-2-2013
Insider Buy |
Jong Joseph Kim
Chief Executive Officer |
$0.50
CAGR »
|
$45,180.00
90,000 shares |
3-22-2013
Insider Buy |
Angel Cabrera
Director |
$0.54
CAGR »
|
$21,592.00
40,000 shares |
3-20-2013
Insider Buy |
Niranjan Sardesai
Chief Operating Officer |
$0.53
CAGR »
|
$13,327.50
25,000 shares |
3-20-2013
Insider Buy |
Jong Joseph Kim
Chief Executive Officer |
$0.53
CAGR »
|
$31,680.00
60,000 shares |
1-15-2013
Insider Buy |
Morton Collins
Director |
$0.67
CAGR »
|
$66,940.00
100,000 shares |
8-15-2012
Insider Buy |
Angel Cabrera
Director |
$0.59
CAGR »
|
$44,250.00
75,000 shares |
6-13-2012
Insider Buy |
Jong Joseph Kim
Chief Executive Officer |
$0.41
CAGR »
|
$6,090.00
15,000 shares |
6-5-2012
Insider Buy |
Jong Joseph Kim
Chief Executive Officer |
$0.41
CAGR »
|
$10,250.00
25,000 shares |
6-5-2012
Insider Buy |
Peter Kies
CFO |
$0.41
CAGR »
|
$10,250.00
25,000 shares |
5-16-2012
Insider Buy |
Niranjan Sardesai
Chief Operating Officer |
$0.45
CAGR »
|
$4,500.00
10,000 shares |
5-10-2012
Insider Buy |
Jong Joseph Kim
Chief Executive Officer |
$0.48
CAGR »
|
$24,000.00
50,000 shares |
3-22-2012
Insider Buy |
Jong Joseph Kim
Chief Executive Officer |
$0.62
CAGR »
|
$30,878.67
50,000 shares |
Also See: Institutional Holders of INO
Also See: SEC filings
Below we present the annualized performance delivered by INO stock since 6-5-2019 (the date of the most recent
insider purchase). The performance of the investment from the time INO insider buying occurred is the ultimate
test of whether insiders were right about INO being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/06/2019 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$27.48 |
|
| End price/share: |
$9.68 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-64.77% |
|
| Average Annual Total Return: |
-19.27% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,522.82 |
|
| Years: |
4.87 |
|
INO Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent INO insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding INO
|
|
Free INO Email Alerts:
